Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of Mirum Pharmaceuticals stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the transaction, the insider now owns 105,254 shares of the company’s stock, valued […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) SVP Jolanda Howe sold 528 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $28.04, for a total transaction of $14,805.12. Following the completion of the transaction, the senior vice president now directly […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of the business’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the sale, the insider now directly owns 105,254 shares of the company’s stock, […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CEO Christopher Peetz sold 5,209 shares of the business’s stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $28.03, for a total value of $146,008.27. Following the completion of the sale, the chief executive officer now directly […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 1,408 shares of the company’s stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $28.03, for a total transaction of $39,466.24. Following the completion of the sale, the chief operating officer now directly […]